Company says its phase 3 trial in the u. S. Found its 72 effective in preventing moderate to severe symptoms and says it will file for Emergency Authorization in the coming week, that could mean approval by the end of february. Heres whats key, the vaccine does not require Ultra Cold Temperatures for storage and Shelf Life Is Good for up to two years, huge win. The other breaking story were following, scientists warning the u. S. Is in a race against time with the new Coronavirus Variants popping up across the country and one of those strains, the South African Variant, is now officially here. Two cases have been confirmed in the state of south carolina. Even more concerning, the state departments Public Health warning says that two infected adults had no recent travel history and no connection to one another. And its raising concerns the strain may already be circulating within the community as new data indicates the vaccines we have may be less effective against this one. That said,
christine and i got was based off of the original strain. it wasn t based off of omicron. which one will the kids get? i believe again we don t do science by press release, so the data is not all out, but i believe that it is based on the ancestral strain. so we ll see as it comes out. and moderna says that the vaccine shows a favorable safety profile but the efficacy rate is not high. why is it it worth getting kidsx natured is the likelihood of they willing ill is low? well, we know that children are not supposed to die so any layers of protection that we can offer this study was a bridging study to look for the best doses, to look for the appropriate immune response and it met the goals,
advisory director before to the cdc director. how confident are you that kids under 5 could get vaccinated, i don t know, before the end of march? i don t know. we ll know when we see the data. when we looked at the 5 to 11-year-old, there was really no difference in the immune response at the 10 microgram dose, given two doses three weeks apart in the 5, 6, 7, 8, 9, 10, 11. they all had the same immune response. apparently that s not true in the 5 and under group. it looks like it would be effective in the youngest child but not in the oldist child. we re all guessing. wool see whether or not this is going to be different doses for different ages or whether it s going to be more than two doses for different ages. time will tell. we ll see. right now we re sort of in an age of science by press release so it s a little confusing. dr. pernell and dr. offit, thank you. president biden promised there could be covid tests for everyone. that hasn t happened. why not?
better reaction to the two doses. tell me if i m wrong. why did they just not segment then to 6-year-olds to try to get approval for them and leave the 2 to 5-year-olds for another batch of research? right. the child who was left 2 years of age and less had a better immune response. but not necessarily better efficacy. the 3 to 4-year-old didn t meet the defind criteria for immune response. who knows? once we see all the data, we haven t seen in i data yet. we re in an age of science by press release. i think once we see all the data that we can make a better give better advice to the fda. are you seeing many young kids in the hospital with covid-19? the last time i was on service was a few weeks ago, yeah, we made it to almost two dozen children. but right now the numbers in our hospitals dramatically decline. not just in terms of people, children admitted for covid-19, but children admitted with
even though they re not guarantees, should dr. fauci stop making predictions like you ll have this before halloween or whatever because it seems so imprecise? well, we ll see how this plays out. the fda s vaccine advisory committee will meet tomorrow. a day-long discussion. then it will take a couple of days for the fda to accept or not accept what our advice is and then it goes to the cdc which is the recommending body on november 2nd and 3rd. so pretty close. i think he was if this all works out that it is recommended, he was close. but again, i would caution that we need to see how tomorrow s fda vaccine advisory meeting plays out. moderna just released its own data on kids 6 to 11 saying their dose produced a, quote, robust immune response. data we should note has not been peer reviewed yet but how promising do you find this initial information? i m where you are on this. science by press release. what i would love to see and we ll see at the fda vaccine